Daiichi Sankyo (DSNKY) News Today $37.03 -0.57 (-1.52%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 18, 2024 | americanbankingnews.comDaiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Sees Significant Growth in Short InterestJuly 10, 2024 | businesswire.comDaiichi Sankyo Opens New Affiliate for Oncology in GreeceMay 27, 2024 | marketwatch.comAstraZeneca, Daiichi Sankyo's Experimental Lung Cancer Drug Shows Improvement in PatientsMay 21, 2024 | finance.yahoo.comDaiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCOMay 7, 2024 | finance.yahoo.comHeart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock SoarsApril 30, 2024 | investorplace.comDSNKY Stock Earnings: Daiichi Sankyo Co Reported Results for Q3 2023April 29, 2024 | finance.yahoo.comAstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival ImprovementMarch 13, 2024 | msn.comMHRA authorises Daiichi Sankyo quizartinib for AML for marketingMarch 2, 2024 | msn.comPfizer, Gilead, Roche seen benefitting the most from antibody-drug conjugatesFebruary 25, 2024 | wsj.comDaiichi Sankyo Co. Ltd. ADRFebruary 19, 2024 | finance.yahoo.comDatopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung CancerFebruary 16, 2024 | morningstar.comDaiichi Sankyo Co Ltd 4568February 16, 2024 | news.yahoo.comDaiichi invests 1 billion eur near Munich to make precision cancer drugsFebruary 16, 2024 | finance.yahoo.comDaiichi invests 1 bln eur near Munich to make precision cancer drugsFebruary 2, 2024 | finance.yahoo.comQ4 2023 Merck & Co Inc Earnings CallJanuary 25, 2024 | msn.comWhat's Going On With Pfizer Stock Today?January 17, 2024 | markets.businessinsider.comUS Patent Office Invalidates Seagen Patent In Daiichi Sankyo Dispute - Quick FactsJanuary 17, 2024 | finance.yahoo.comU.S. Patent Office Invalidates Seagen Patent in Dispute between Daiichi Sankyo and SeagenJanuary 3, 2024 | marketwatch.comEsperion Therapeutics, Daiichi Sankyo Europe Reach $125M Payment Agreement Over Commercial LitigationJanuary 3, 2024 | msn.comWhy Pharmaceutical Company Esperion Therapeutics Shares Are Diving TodayDecember 22, 2023 | markets.businessinsider.comMerck, Daiichi Sankyo Say FDA Grants Priority Review In U.S. For Patritumab DeruxtecanDecember 22, 2023 | finance.yahoo.comPatritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung CancerDecember 17, 2023 | msn.comDaiichi Sankyo Co., - ADR (DSNKY) Price Target Increased by 8.80% to 38.57December 12, 2023 | businesswire.comDepixus Announces Strategic Collaboration With Daiichi Sankyo to Use MAGNA™ Technology to Accelerate RNA-targeted Drug DiscoveryDecember 1, 2023 | baystreet.ca300,000 New Cases: The Role of Biotech in Addressing Rising Breast Cancer RatesDecember 1, 2023 | businesswire.comDaiichi Sankyo Demonstrates Breadth and Depth of Oncology Portfolio Across Multiple Cancers with New Data at ESMO Asia, SABCS and ASHNovember 27, 2023 | finance.yahoo.comJapan panel recommends approval of updated Daiichi Sankyo COVID shot- KyodoOctober 31, 2023 | investing.comDaiichi Sankyo Co., Ltd. (4568)October 31, 2023 | finance.yahoo.comMerck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?October 26, 2023 | finance.yahoo.comMerck (MRK) Q3 Earnings Top Estimates, COVID Drug Boosts SalesOctober 26, 2023 | finance.yahoo.com‘Guided Missile Drugs’ Could Be Big Pharma’s Secret WeaponOctober 23, 2023 | bloomberg.comMerck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo DealOctober 22, 2023 | finance.yahoo.comRaludotatug Deruxtecan Continues to Demonstrate Promising Clinical Activity in Patients with Advanced Ovarian Cancer in Early TrialOctober 20, 2023 | finance.yahoo.comNikkei Falls 0.5%, Dragged by Electronics, Retail StocksOctober 20, 2023 | news.yahoo.comMerck teams up with Daiichi Sankyo on antibody drug conjugate collaborationOctober 20, 2023 | barrons.comJapan's Daiichi Sankyo, Merck Announce $22bn Cancer Drug DealOctober 20, 2023 | reuters.comMerck signs $5.5 bln deal with Daiichi for cancer therapy developmentOctober 18, 2023 | finance.yahoo.comExperimental Drug Wards Off Both Lung and Breast Cancer Progression in TrialsOctober 16, 2023 | finance.yahoo.comDaiichi Sankyo Showcases Progress in Developing New Standards of Care for Patients with Industry-Leading DXd ADC Portfolio Across Multiple Cancers at ESMOSeptember 26, 2023 | finance.yahoo.comNikkei Falls 1.1%, Dragged by Pharma, Electronics StocksSeptember 25, 2023 | finance.yahoo.comU.S. Stocks Open Lower After S&P 500 Logs Three Straight Weeks Of LossesSeptember 25, 2023 | finance.yahoo.comDaiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer DrugSeptember 25, 2023 | finance.yahoo.comStock Market Today: Bond Yields Climb Toward 4.5%September 24, 2023 | finance.yahoo.comNikkei Flat, Supported by Electronics, Pharma StocksSeptember 22, 2023 | finance.yahoo.comDatopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 TrialSeptember 22, 2023 | finance.yahoo.comAstraZeneca Surges To 50-Day Line After Breast Cancer Drug Tops ChemoSeptember 15, 2023 | lse.co.ukAstraZeneca and Daiichi Sankyo's Enhertu recommended for approvalSeptember 15, 2023 | finance.yahoo.comUPDATE 1-EU regulator backs AstraZeneca and Daiichi's lung cancer drugSeptember 12, 2023 | bloomberg.comDaiichi to File for US Approval of New Lung Cancer Drug by MarchSeptember 10, 2023 | finance.yahoo.comPatritumab Deruxtecan Demonstrated Clinically Meaningful and Durable Responses in Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer in HERTHENA-Lung01 Phase 2 Trial Get Daiichi Sankyo News Delivered to You Automatically Sign up to receive the latest news and ratings for DSNKY and its competitors with MarketBeat's FREE daily newsletter. Email Address J.P. Morgan’s DIRE Warning (Ad)When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell." Click here to see why Wall Street is in PANIC mode >>> DSNKY Media Mentions By Week DSNKY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DSNKY News Sentiment▼-1.000.62▲Average Medical News Sentiment DSNKY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DSNKY Articles This Week▼11▲DSNKY Articles Average Week Get Daiichi Sankyo News Delivered to You Automatically Sign up to receive the latest news and ratings for DSNKY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AstraZeneca News Today JCR Pharmaceuticals News Today Kyowa Kirin News Today Mayne Pharma Group News Today Ono Pharmaceutical News Today Otsuka News Today Roche News Today Sanofi News Today Virbac News Today 1933 Industries News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:DSNKY) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daiichi Sankyo Company, Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Daiichi Sankyo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
